BRK-B vs NBHC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
NBHC presents a contradictory profile characterized by a very weak Piotroski F-Score of 2/9, indicating significant deterioration in fundamental financial health. While the stock trades below its Graham Number ($47.02), suggesting defensive value, it is priced far above its growth-based intrinsic value ($18.76). Strong top-line revenue growth (33.7%) is currently offset by a sharp decline in earnings growth (-27%), creating a divergence between scale and profitability. Despite bullish analyst targets, the combination of poor health scores, bearish insider sentiment, and negative earnings momentum warrants a cautious approach.
Compare Another Pair
Related Comparisons
BRK-B vs NBHC: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and National Bank Holdings Corporation (NBHC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.